57404-88-3

Usage

Uses

Used in Research and Development:
TRANS-7,8-DIHYDROXY-7,8-DIHYDRO-BENZO(A)PYRENE is used as a research compound for studying the metabolism and carcinogenic properties of PAHs, specifically Benzo[a]pyrene. Its role in forming DNA-adducts makes it a valuable tool for understanding the molecular mechanisms underlying PAH-induced carcinogenesis.
Used in Environmental and Occupational Health:
TRANS-7,8-DIHYDROXY-7,8-DIHYDRO-BENZO(A)PYRENE is used as a biomarker for exposure to PAHs in various environmental and occupational settings. Monitoring the levels of this metabolite can help assess the risk of PAH exposure and its potential health impacts on human populations.
Used in Pharmaceutical Development:
TRANS-7,8-DIHYDROXY-7,8-DIHYDRO-BENZO(A)PYRENE serves as a target for the development of new drugs aimed at mitigating the harmful effects of PAH exposure. By understanding its interaction with DNA and its role in carcinogenesis, researchers can design drugs that interfere with these processes, potentially reducing the risk of PAH-induced cancers.
Used in Toxicology Studies:
TRANS-7,8-DIHYDROXY-7,8-DIHYDRO-BENZO(A)PYRENE is used as a toxicological endpoint in studies evaluating the toxic effects of PAHs and their metabolites. TRANS-7,8-DIHYDROXY-7,8-DIHYDRO-BENZO(A)PYRENE's ability to form DNA-adducts makes it a relevant indicator of the toxic potential of PAHs and their impact on cellular processes and overall health.

InChI:InChI=1/C20H14O2/c21-16-9-7-14-10-13-5-4-11-2-1-3-12-6-8-15(18(13)17(11)12)19(14)20(16)22/h1-10,16,20-22H/t16-,20+/m0/s1

Upstream product

• 65199-11-3 benzo[a]pyren-7,8-dione 
• 50-32-8 benzopyrene 
• 156641-98-4 (6-methoxy-2-naphthalene)boronic acid 
• 6751-75-3 2-bromoresorcinol 
• 16932-45-9 1-bromo-2,6-dimethoxybenzene 
• 19821-80-8 1,3-dibromo-2-iodo-benzene 
• 115237-06-4 (((2-bromo-1,3-phenylene)bis(oxy))bis(methylene))dibenzene 
• 57405-01-3 C₃₄H₂₃BrO₄ 
• 57405-00-2 (+/-)-7,8,9,10-Tetrahydrobenzopyrene-trans-7,8-diol dibenzoate 
• 6272-55-5 7-hydroxy-7,8,9,10-tetrahydrobenzopyrene 
• 17573-15-8 9,10-dihydro benzopyrene 
• 678996-94-6 2-(2,6-bis{2-methoxyvinyl}phenyl)-6-methoxynaphthalene 
• 671780-70-4 2-methoxy-6-(2,6-divinylphenyl)naphthalene 
• 671780-69-1 2-(2-methoxynaphthalen-6-yl)benzene-1,3-dialdehyde 

Downstream Products

• 37994-82-4 7-Hydroxybenzo[a]pyrene 
• 13345-26-1 7-hydroxy benzopyrene 
• 61490-66-2 7,8,9,10-tetrahydroxytetrahydrobenzopyrene 
• 62697-16-9 (+/-)-7β,8α,9α,10α-tetrahydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene 
• 62697-17-0 r-7,t-8,10,c-9-tetrahydroxy-7,8,9,10-tetrahydrobenzopyrene 
• 62697-13-6 (+/-)-7β,8α,9β,10β-tetrahydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene 
• 63323-30-8 (+/-)-r-7,t-8-Dihydroxy-t-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene 
• 58917-91-2 (+/-)-7α,8β-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene 
• 60864-95-1 (-)-7R-trans-Benzopyrene-7,8-dihydrodiol 
• 62314-67-4 (+/-)-trans-7,8-Dihydrobenzo[a]pyrene-7,8-diol 

Relevant academic research and scientific papers

Synthesis of 13C4-labelled oxidized metabolites of the carcinogenic polycyclic aromatic hydrocarbon benzo[a]pyrene

Polycyclic aromatic hydrocarbons (PAHs), such as benzo[a]pyrene (BaP), are ubiquitous environmental contaminants that are implicated in causing lung cancer. BaP is a component of tobacco smoke that is transformed enzymatically to active forms that interact with DNA. We reported previously development of a sensitive stable isotope dilution LC/MS method for analysis of BaP metabolites. We now report efficient syntheses of 13C4-BaP and the complete set of its 13C4-labelled oxidized metabolites needed as internal standards They include the metabolites not involved in carcinogenesis (Group A) and the metabolites implicated in initiation of cancer (Group B). The synthetic approach is novel, entailing use of Pd-catalyzed Suzuki, Sonogashira, and Hartwig cross-coupling reactions combined with PtCl2-catalyzed cyclization of acetylenic compounds. This synthetic method requires fewer steps, employs milder conditions, and product isolation is simpler than conventional methods of PAH synthesis. The syntheses of 13C4-BaP and 13C4-BaP-8-ol each require only four steps, and the 13C-atoms are all introduced in a single step. 13C4-BaP-8-ol serves as the synthetic precursor of all the oxidized metabolites of 13C-BaP implicated in initiation of cancer. The isotopic purities of the synthetic 13C 4-BaP metabolites were estimated to be ≥99.9%.

Highly diastereoselective synthesis of nucleoside adducts from the carcinogenic benzo[a]pyrene diol epoxide and a computational analysis

A diastereoselective synthesis of the nucleoside adducts corresponding to a cis ring-opening of the carcinogen (±)-7β,8α-dihydroxy- 9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BaP DE-2) by 2′-deoxyadenosine and 2′-deoxyguanosine is described. The key

Synthesis of the o-Quinones and Other Oxidized Metabolites of Polycyclic Aromatic Hydrocarbons Implicated in Carcinogenesis

Efficient new syntheses of the o-quinone derivatives of benzo[a]pyrene (BPQ), 7,12-dimethylbenz-[a] anthracene (DMBAQ), and benz[a]anthracene (BAQ), implicated as active carcinogenic metabolites of the parent polycyclic aromatic hydrocarbons (PAHs), are reported. These PAH quinones also serve as starting compounds for the synthesis of the other active metabolites of these PAHs thought to be involved in their mechanism(s) of carcinogenesis. The latter include the corresponding o-catechols, trans-dihydrodiols, and the corresponding anti- and syn-diol epoxides.

Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7,8- dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase

Recombinant human enzymes expressed in membranes obtained from Escherichia coli transformed with cytochrome P450 (P450) and NADPH-P450 reductase cDNAs were used to identify the human P450 enzymes that are most active in catalyzing the oxidative transformation of benzo[a]pyrene in vitro. Activation of benzo[a]pyrene to genotoxic products that cause induction of umu gene expression in Salmonella typhimurium NM2009 by P450 1A1 and P450 1B1 enzymes was found to be enhanced by inclusion of purified epoxide hydrolase (isolated from rat or human livers) with the reaction mixture. High- performance liquid chromatographic analysis showed that P450 1B1 catalyzed benzo[a]pyrene to trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene at level of ~3 nmol min-1 nmol of P450-1 only when epoxide hydrolase was present and P450 1A1 (with the hydrolase) was able to catalyze benzo[a]pyrene at one- tenth of the activity catalyzed by P450 1B1. Kinetic analysis showed that ratio of V(max) to K(m) for the formation of trans-7,8-dihydroxy-7,8- dihydrobenzo[a]pyrene in this assay system was 3.2-fold higher in CYP1B1 than in CYP1A1. Other human P450s (including P450s 1A2, 2E1, and 3A4) were found to have very low or undetectable activities toward the formation of trans- 7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene. A reconstituted system containing purified P450 1B1, rabbit liver NADPH-P450 reductase, and human liver epoxide hydrolase was found to catalyze benzo[a]pyrene to trans-7,8-dihydroxy-7,8- dihydrobenzo[a]pyrene at a rate of 0.86 nmol min-1 nmol of P450-1; the activities were found to be largely dependent on the presence of sodium cholate in the system. These results suggest that P450 1B1 is a principal enzyme in catalyzing the oxidation of benzo[a]pyrene to trans-7,8-dihydroxy- 7,8-dihydrobenzo[a]pyrene and that the catalytic functions of P450 1B1 may determine the susceptibilities of individuals to benzo[a]-pyrene carcinogenesis.

Preparation of Enantiomers of (+/-)-trans-7β,8α-Dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzopyrene

(+/-)-trans-7,8-Dihydroxy-7,8-dihydrobenzopyrene (VII), obtained from 7,8,9,10-tetrahydrobenzopyrene-7(8H)-one (I) by modifications and improvements of the reported procedures, has been converted into its di-(-) and (+)-menthoxyacetate derivatives in 82percent yield.The diastereomers have been separated by liquid chromatography on Lichrosorp Si 60 (30μ) column (100 cm x 1 cm dia.) using methylene chloride-ethyl acetate (99.4/0.6, v/v) as eluant.The enantiomers are liberated from the separated diastereomers by methanolysis with catalytic amount of sodium methoxide and converted into the enantiomers of (+/-)-trans-7β,8α-dihydroxy- 9α,10α-epoxy-7,8,9,10-tetrahydrobenzopyrene by m-chloroperbenzoic acid in an overall yield of 30percent.The CD and the UV spectra of the diastereomers and the enantiomers are reported.